Lynch Syndrome Integrative Epidemiology and Genetics

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2054

Study Completion Date

December 31, 2054

Conditions
Lynch Syndrome
Trial Locations (2)

60637

NOT_YET_RECRUITING

University of Chicago, Chicago

80045

RECRUITING

University of Colorado, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

University of Kansas

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

City of Hope National Medical Center

OTHER

collaborator

Loma Linda University

OTHER

collaborator

MedStar Health

OTHER

collaborator

University of Arizona

OTHER

collaborator

University of Manitoba

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of North Carolina

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

University of Rochester

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Kaiser Permanente

OTHER

collaborator

Ohio State University

OTHER

collaborator

Virginia Mason Hospital/Medical Center

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of Miami

OTHER

lead

University of Colorado, Denver

OTHER

NCT06582914 - Lynch Syndrome Integrative Epidemiology and Genetics | Biotech Hunter | Biotech Hunter